Oral streptococci are major pathogens of infective endocarditis. Prophylactic antibiotics are commonly given to subjects with certain kinds of heart disorders when invasive dental treatments are performed, with amoxicillin (AMPC) being widely used for this purpose. However, there is little information regarding AMPC-resistant oral streptococci. Here, a total of 344 dental plaque specimens collected from 253 healthy Japanese children, adolescents and young adults (aged 2-22 years) were diluted and streaked onto culture medium containing high-dose AMPC. The MICs for the isolated strains were evaluated using a macrodilution broth method described by the Clinical and Laboratory Standards Institute. Bacterial DNA was extracted from each strain and the entire sequences of the 16S rRNA gene were compared with those in GenBank to identify the species. The results showed that strains with AMPC MICs .16 mg ml "1 were isolated from 18 specimens from 14 patients. Analyses of the 16S rRNA gene sequences of these strains identified them as major oral streptococcal species, including Streptococcus oralis and Streptococcus mitis. These findings indicate that oral streptococci with elevated MICs for AMPC exist in certain small populations of healthy children, and highlight the need for further studies to determine risk factors that lead to the appearance of such strains.
INTRODUCTION
Infective endocarditis (IE), a well-known disease in the field of dentistry, is initiated by bacterial adherence to heart valves with pre-existing damage during transient bacteraemia. A review of cases published between 1993 and 2003 revealed an annual median incidence of 3.6 per 100 000 of the population, with a median in-hospital mortality rate of 16 % (Moreillon & Que, 2004) . Whilst staphylococci are more often identified in Western countries, oral streptococci are regarded as the major pathogens of IE in Japan (Nakatani et al., 2003; Moreillon & Que, 2004) . Bacteraemia is thought to be induced by invasive dental procedures, such as tooth extraction and periodontal surgery, and prophylaxis for IE using antibiotics is recommended when invasive dental procedures are performed for patients at risk for IE (Wahl & Pallasch, 2005) . The British Society for Antimicrobial Chemotherapy recommends the use of a mouth rinse containing 0.2 % chlorhexidine digluconate (Gould et al., 2006) . In contrast, the American Heart Association (AHA) and National Institute of Health and Clinical Excellence of the UK do not recommend chlorhexidine as a prophylaxis to prevent IE (Wilson et al., 2007; NICE, 2008) . Amoxicillin (AMPC) is the most commonly recommended prophylactic regimen in guidelines for IE prevention and is generally used in daily practice (Dajani et al., 1997; Nakatani et al., 2003; Wilson et al., 2007; Nakano & Ooshima, 2011) .
Ten years ago, more prescriptive guidelines were proposed in order to reduce misuse and overprescription of antibiotics (Seymour et al., 2000) . It is widely reported that bacteraemia can be induced not only by invasive dental procedures but also by other dentogingival manipulative procedures, such as rubber dam placement, and use of a matrix band and wedge and orthodontic separators, whilst even tooth brushing and dental flossing procedures have been implicated, although the incidence of IE related to these is quite low (Sonbol et al., 2009) . The current guidelines for prevention of IE presented by the American Heart Association designate overall dental procedures in the highest risk subjects as a category that requires prevention (Wilson et al., 2007) , whereas the European Heart Society designates limited procedures, such as those requiring manipulation of gingival or periapical regions of the teeth, or perforation of oral mucosa (Habib et al., 2009) . In contrast, the latest guidelines from the Japan Circulation Society designate manipulation causing severe bleeding, such as tooth extraction, periodontal surgery and scaling, as well as others. Each of these guidelines recommends that oral AMPC [2.0 g for adults, 50 mg (kg body weight) 21 for children] generally be given as prophylaxis. Nevertheless, evidence connecting bacteraemia to IE is controversial, as a recent review suggested that scientific evidence showing the effectiveness of AMPC for reducing the onset of IE is lacking, and recommended a search for alternative antimicrobials (Tomás Carmona et al., 2007) . In addition, recent reports of IE cases in Taiwan have shown an increase in streptococcal strains with high resistance to penicillin, in which the MICs for 7 of 62 isolates (11 %) were ¢2 mg ml 21 (Hsu & Lin, 2006) . In the present study, we investigated the presence of AMPC-resistant oral streptococcal strains using dental plaque specimens collected from 253 systemically healthy Japanese children, adolescents and young adults.
METHODS
Patients and clinical specimens. The protocols used in this study were approved by the Ethics Committee of Osaka University Graduate School of Dentistry (reference no. H22-E1). Before collecting specimens, the subjects were informed of the study contents and gave approval for their participation, with that for children and adolescents being provided by their guardians. The subjects were children, adolescents and young adults who came to Osaka University Dental Hospital from July 2008 to March 2010 for dental treatment or periodic examination. Only those who were systemically healthy and had not taken antibiotics for at least 3 months were included. In total, 344 dental plaque specimens were collected from 125 males and 128 females (age range 2-22 years; see Supplementary Fig. S1 , available in JMM Online). Following mouth washing with water, supra-and subgingival plaque specimens were collected from all teeth with a sterile instrument, placed into sterile plastic tubes in sterile saline on ice and immediately transported to our laboratory, where the following procedures were performed.
Isolation of AMPC-resistant oral streptococcal strains. The dental plaque specimens were serially diluted in sterile saline, streaked onto mitis salivarius (MS) agar (Difco Laboratories) plates, with or without AMPC (32 mg ml 21 ), and incubated anaerobically at 37 uC for 48 h. Total numbers of streptococci were estimated based on the numbers of colonies on the MS agar plates. The MS agar containing AMPC (MS-AMPC) was then observed, and four representative colonies, or all colonies if fewer than four, were taken from each MS-AMPC plate and grown anaerobically in brain-heart infusion (BHI) broth (Difco Laboratories) at 37 uC for 18 h. To identify different clones, randomly amplified polymorphic DNA (RAPD) analysis was performed using Ready-To-Go RAPD analysis beads and primers (Amersham Biosciences), as described previously (Nomura et al., 2006) . Briefly, PCR was performed using six primers (P1, 59-GGTG-CGGGAA-39; P2, 59-GTTTCGCTCC-39; P3, 59-GTAGACCCGT-39; P4, 59-AAGAGCCCGT-39; P5, 59-AACGCGCAAC-39; P6, 59-CCC-GTCAGCA-39) and comprised 45 cycles of denaturation at 94 uC for 30 s, annealing at 36 uC for 30 s and extension at 72 uC for 1 min. Amplicons were separated by electrophoresis on 1.5 % agarose gels.
Determination of AMPC MICs. AMPC MICs were determined using a macrodilution broth method (CLSI, 2006) . Briefly, samples consisting of 950 ml Mueller-Hinton broth (Difco Laboratories) supplemented with 5 % defibrinated sheep blood (Nippon Biotest Laboratories) and containing a twofold serial dilution of AMPC were placed in sterile 136100 mm test tubes. Test strains were cultured in BHI broth at 37 uC for 18 h, then washed and adjusted to 1610 7 c.f.u. ml
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. Thereafter, 50 ml samples of the diluted test strains (5610 5 c.f.u.) were added to tubes containing the antimicrobial agents and incubated anaerobically at 37 uC for 18 h. The breakpoints of AMPC concentration were set based on the Clinical and Laboratory Standards Institute recommendations (CLSI, 2006) Identification of bacterial species. Genomic DNA was extracted from each strain using a conventional method. Briefly, bacterial cells were collected in a microcentrifuge tube and incubated with N-acetylmuramidase SG (Seikagaku) and lysozyme (Wako Pure Chemical Industries). Genomic DNA was then extracted using a Gentra Puregene Yeast/Bact. kit B (Qiagen), according to the manufacturer's instructions. Next, 16S rRNA gene sequences of 1500 bp were amplified by PCR using AmpliTaq Gold polymerase (Applied Biosystems) with primers 8UA (59-AGAGTTTGATCCTG-GCTCAG-39) and 1540R (59-AAGGAGGTGATCCAGCC-39), which have been described previously (Fujiwara et al., 2001) . The sequences obtained were compared with those available in GenBank using the gapped BLASTN version 2.0.5 program obtained from the National Center for Biotechnology Information server (http://blast.ncbi.nlm.nih. gov/Blast.cgi).
AMPC susceptibility of streptococcal strains isolated from blood. A total of 39 streptococcal strains in our laboratory stocks that originated from blood samples from the Tokyo Women's Medical College (TW) series obtained from patients with IE, bacteraemia and sepsis, comprising 18 Streptococcus sanguinis, 10 Streptococcus mitis, 5 Streptococcus oralis, 4 Streptococcus mutans and 2 Streptococcus gordonii strains, were isolated and tested for AMPC MICs as described above (see Supplementary Table S1 , available in JMM Online). These strains were isolated between the late 1980s and early 1990s.
Evaluation of resistance to other antibiotics. The MICs of four other antibiotics, ampicillin (ABPC), penicillin G (PCG), erythromycin (EM) and levofloxacin (LVFX), for the AMPC-resistant strains were also evaluated using the method described above. In addition, MICs for representative strains of six different oral streptococcal species (S. sanguinis, S. oralis, S. gordonii, S. mitis, S. mutans and Streptococcus salivarius) of AMPC and the four other antibiotics were also determined. The breakpoints (susceptible, intermediate and resistant) for each antibiotic were obtained following the CLSI (2006) recommendations.
RESULTS

Identification of AMPC-resistant strains
Analysis of 344 dental plaque specimens from 253 patients showed that the total number of streptococci in each specimen ranged from 3.3610 3 to 8.0610 7 c.f.u. (see Supplementary Fig. S2 ). Of these, 18 strains (5.2 % of all specimens) from 14 patients (5.5 % of all patients) were shown to be highly resistant to AMPC (Table 1) . The subjects consisted of ten boys and four girls, and the total number of streptococci in each resistant specimen ranged from 2.0610 2 to 2.5610 6 c.f.u. Based on nucleotide alignment of the 16S rRNA gene, the isolated strain species were determined to be S. oralis (n58), S. mitis (n55), S. salivarius (n52), S. sanguinis (n51), Streptococcus parasanguinis (n51) and Streptococcus australis (n51). The AMPC MICs for these strains ranged from 16 to 64 mg ml 21 , which were much higher than those for the six reference strains (S. sanguinis, S. oralis, S. gordonii. S. mitis, S. mutans and S. salivarius; 0.063-0.25 mg ml 21 ; Table 2 ). When resistance to ABPC, PCG and EM was compared, the MICs of these antibiotics for the AMPC-resistant strains were much greater than those for the six reference strains, whereas the MICs for the AMPC-resistant strains of LVFX were similar to, or higher than, those for the reference strains.
Analysis of AMPC-resistant strains isolated at different times
Dental plaque specimens were collected more than twice at different times from 8 of the 14 subjects with AMPCresistant strains. Only two of the subjects (subjects A and H) were shown to possess AMPC-resistant strains at different times (Fig. 1a) . In subject A, the fingerprinting patterns of the two strains were not consistent, whereas those of all strains isolated at three different times were consistent in subject H (Fig. 1b) .
Evaluation of AMPC susceptibility of blood isolates
The 39 blood isolates obtained from patients with IE, bacteraemia after tooth extraction or sepsis between the late 1980s and early 1990s (TW series) consisted of 18 S. sanguinis, 10 S. mitis, 5 S. oralis, 4 S. mutans and 2 S. gordonii strains, as determined based on 16S rRNA gene alignment. The MICs for these strains ranged from 0.063 to 1 mg ml 21 (Table 3 and Supplementary Table S1 ), which was quite similar to those for the reference strains (Table 2) .
DISCUSSION
Several guidelines for IE prevention have been published worldwide and updated based on accumulated scientific evidence (Harrison et al., 2008) . Although designations of high-risk subjects and risky procedures requiring prophylaxis for IE have changed, AMPC is still recommended as the major antibiotic for this purpose. However, there is limited information regarding the resistance of oral streptococcal strains to possible preventive agents for IE, whilst prophylaxis for IE has been reported to fail in several cases due to the presence of strains with high MIC values (1-3 mg ml 21 ) and shown to be causative agents for IE (Hall & Baddour, 2002 Bavunoglu et al., 2007) . Therefore, we consider it important to estimate how many strains with high MIC values exist in the oral cavities of Japanese individuals.
Notably, analyses of the multiple specimens collected at different times showed that strains with high MIC values were detected only once in most of the present subjects. Therefore, we speculated that these were probably transient and not inhabitants of the oral cavity. In subject A, the strains were isolated at the first and fourth collections, which had an interval of 4 months. However, their fingerprinting patterns were totally different, indicating that these could also have been transient strains. In contrast, the fingerprinting patterns of the three strains isolated from subject H on three consecutive occasions within 3 months were consistent, suggesting that these strains were stable in that individual.
In order to obtain a large number of specimens, we analysed systemically healthy patients who visited our clinic. Therefore, the distribution frequency of strains in this study came from healthy subjects without a risk for IE. The AMPC MICs for streptococci isolated from the blood of healthy adults in Spain were reported to range from 0.016 to 4 mg ml
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, among which only 7.5 % of the strains belonged to the intermediately resistant group and none were classified into the highly resistant group (Tomás et al., 2004) . In contrast, the mean AMPC MIC for 29 S. sanguinis strains isolated from dental plaque samples obtained from 21 children after frequent antibiotic therapy for otitis media was 3.2 mg ml 21 (Erickson & Herzberg, 1999) , indicating that the rate of AMPC-resistant strains might be higher in subjects at risk for IE. In addition, it is possible that there is increased likelihood of antibodyresistant isolates harboured by patients exposed to frequent prophylactic courses of antimicrobials to prevent IE compared with the healthy subjects investigated in the present study. In fact, a recent study conducted in Brazil of 30 patients at high risk for IE using an agar susceptibility test showed a detection rate of 16.7 % for AMPC-resistant streptococcal strains in saliva specimens (Groppo et al., 2005) . Therefore, future studies should focus on risk factors for the acquisition of AMPC-resistant isolates.
It was reported previously that the mean serum level 4 h after oral administration of 3 g AMPC in 24 subjects aged ¢12 years was 9 mg ml 21 (Cannon et al., 1984) . In contrast, the mean serum concentrations after receiving 2 or 3 g AMPC in 30 adults were 12.8 and 16.5 mg ml 21 , respectively (Dajani et al., 1994) . In terms of the concentration of AMPC in the oral cavity, ranges of 0.1-0.5 mg ml 21 in saliva and 1-14 mg ml 21 in gingival (Stewart et al., 1970; Nelson et al., 1981; Akimoto et al., 1985; Tenenbaum et al., 1997) . Thus, in the present study, we attempted to identify strains with an AMPC MIC of .16 mg ml 21 . Use of a set concentration of AMPC (32 mg ml 21 ) in the MS agar plates enabled us to isolate AMPC-resistant strains with MICs of ¢16 mg ml 21 using the CLSI method, which indicated the appropriateness of the first screening step in this study.
AMPC has long been used throughout the world as a general regimen for IE prevention. In the present study, we found that the MICs for the strains in blood samples from patients obtained between the late 1980s and early 1990s were not high. However, susceptibility to an antibiotic can be changed by its long-time use, as noted by a report that analysed oral streptococcal isolates obtained from IE patients during 1971-1986 and 1994-2002 in the USA (Prabhu et al., 2004) . In that report, the MIC 90 value of penicillin in the period 1971-1986 was reported to be 0.125 mg ml
, whereas that in the period 1994-2002 increased to 0.5 mg ml
. In addition, a recent study of 129 blood isolates from patients with septicaemia or IE in Sweden showed reduced penicillin susceptibility (MIC of ¢0.25 mg ml 21 ) in 18 % of the isolates and penicillin resistance in 4 % (MIC of ¢4.0 mg ml 21 ), although the penicillin resistance levels in that study were lower than in those performed in other countries (Westling et al., 2006) . In addition, a survey of 155 consecutive oral streptococci blood isolates obtained in the UK from 1993 to 2000 revealed that the rates of S. oralis (n567), S. mitis (n566) and S. sanguinis (n57) strains with an MIC of ¢2 mg ml 21 were 27, 11 and 14 %, respectively (Smith et al., 2004) . As regional variations for the susceptibility to AMPC may exist, a worldwide survey may be required.
When strains with high AMPC MICs are found in patients at risk of IE, other antibiotics should be selected prior to invasive dental procedures associated with bacteraemia by analysing antibiotic susceptibility test results. Furthermore, clinical approaches to identify the presence of antibioticresistant strains might be important in the near future. In the present study, AMPC-resistant strains were also shown to be resistant to other tested antibiotics, except for LVFX. It is suggested that selection of an antibiotic other than AMPC should be considered when patients with AMPCresistant strains are treated. In this regard, the level of resistance that would necessitate a change in the prophylactic prescribing pattern must be established. Further clinical studies are required to elucidate this point. (a) AMPC-resistant strains were isolated from 14 patients, with clinical specimens obtained from eight more than twice at different times. Letters representing patients correspond to those shown in Table 1 . Open and filled rectangles indicate no isolation and isolation, respectively, of the resistant strains. a1, a2 and h1-h3 in the filled rectangles represent isolates subjected to RAPD analysis, as described in (b). (b) Representative images of RAPD analysis using primers P3 and P6. Lanes a1, a2 and h1-h3 indicate strains isolated at the time points illustrated in (a). M, 100 bp ladder. 
